m(6)A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD

Lung adenocarcinoma (LUAD) is the most frequent subtype of lung cancer worldwide. However, the survival rate of LUAD patients remains low. N6-methyladenosine (m(6)A) and long noncoding RNAs (lncRNAs) play vital roles in the prognostic value and the immunotherapeutic response of LUAD. Thus, discernin...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mol Ther Nucleic Acids
Asıl Yazarlar: Xu, Feng, Huang, Xiaoling, Li, Yangyi, Chen, Yongsong, Lin, Ling
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Gene & Cell Therapy 2021
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8094594/
https://ncbi.nlm.nih.gov/pubmed/33996259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtn.2021.04.003
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller